The study, published in the Annals of Biomedical Engineering, addresses a long-standing blind spot in ocular biomechanics. Detachment of the Descemet membrane is a recognized complication of cataract surgery, corneal transplantation and certain corneal dystrophies, and it can cause significant corneal swelling and vision loss if the membrane does not reattach. Yet most previous computational examinations of the anterior chamber have treated the eye’s interior as rigid-walled plumbing, focusing on fluid flow or heat transfer while excluding the complex two-way coupling between the intraocular fluid and the fragile ocular structures suspended within it. The new work changes that by modeling the detached Descemet membrane as a deformable, elastic solid that bends, stretches and deforms under the pressure and shear of the aqueous humor flowing around it.

The researchers, led by Ammar I. Alsabery of the Islamic University in Najaf, Iraq, together with colleagues from the University of Basrah, King Khalid University in Saudi Arabia, Saveetha School of Engineering in India, and Universiti Kebangsaan Malaysia, employed a coupled numerical scheme that solves simultaneously for the buoyancy-driven flow of aqueous humor and for the structural deformation of the membrane. The geometry represents the anterior chamber—the fluid-filled space between the cornea and the iris—with a warm region corresponding to the lens contact zone held at an isothermal hot temperature, mimicking the thermal gradients that arise in ocular warming therapies and in normal physiological conditions.

At the heart of the analysis is the Rayleigh number, a dimensionless parameter that governs the strength of natural convection: warmer, less dense fluid rises while cooler fluid sinks, generating circulating currents within the chamber. The team varied the Rayleigh number across three orders of magnitude, from 10³ to 10⁶, which corresponds to temperature differences spanning from a fraction of a degree to 250 Kelvin. This range deliberately encompasses both the mild thermal gradients present in the living eye and the much more aggressive temperature differences applied during clinical thermal therapy of the cornea, allowing the same model to speak to both resting physiology and active treatment.

Equally central to the study is the elasticity modulus of the detached membrane. The researchers swept this property across nine orders of magnitude, from 10⁸ to 10¹¹, a range designed to represent everything from highly compliant, freshly detached tissue to the much stiffer mechanical character of donor corneal tissue used in transplantation. Because the Descemet membrane’s stiffness varies with age, disease state and surgical history, this parametric approach lets the model answer a question that clinicians genuinely care about: does the type of cornea grafted into a patient change the mechanical load experienced by a detached membrane during recovery? The answer, according to the simulations, is nuanced. The cornea type does affect the stress imparted on the detached Descemet membrane, but it does not affect the thermal characteristics of the anterior chamber or the overall displacement behavior within it. In other words, stiffer transplanted tissue changes the mechanical environment at the membrane itself without appreciably altering the convective heat transfer patterns of the aqueous humor circulating beneath it.

The fluid dynamics of the anterior chamber turned out to be far more sensitive to geometry than to tissue stiffness. One of the most striking results concerns the iris, the pigmented diaphragm whose length in the model determines the extent of the hot, isothermal contact region associated with the lens. When the team simulated a shrinkage of the iris—effectively reducing the length of the contacting part of the lens held at the hot temperature—they found that the convective thermal characteristic of the anterior chamber rose by approximately 78 percent. This dramatic enhancement arises because the reduced iris length reshapes the buoyancy-driven circulation cells, allowing warmer fluid to travel more freely and exchange heat more efficiently with its surroundings. For clinicians, the implication is that the geometry of the anterior chamber, shaped in part by the iris and the lens, is a first-order determinant of how heat is distributed during thermal therapy, potentially more important than the material properties of the graft itself.

The temperature difference applied during thermal therapy also proved to be a powerful lever. Raising the applied thermal gradient from 2.5 Kelvin to 25 Kelvin—a tenfold increase—promoted heat transfer within the anterior chamber by 47.6 percent. While the scaling is sublinear rather than directly proportional to the temperature difference, the result confirms that modest increases in therapeutic temperature can yield meaningful gains in convective heat delivery without requiring a hundredfold jump in applied thermal load. The finding offers a quantitative framework for calibrating thermal treatments of the anterior segment: therapy protocols could, in principle, be tuned to achieve target heat transfer rates while respecting the narrow thermal safety margins of living ocular tissue.

Technically, the simulations belong to a class of problems known as fluid–structure interaction, or FSI, in which the fluid equations and the solid mechanics equations are coupled and solved together rather than in isolation. In this case, the aqueous humor—an essentially water-like fluid—drives natural convection under the influence of gravity, while the detached Descemet membrane responds to the pressure and viscous stresses exerted by that flow. The membrane’s deformation, in turn, modifies the shape of the fluid domain, feeding back into the flow field. This two-way coupling is computationally demanding but essential, because a rigid-wall approximation would entirely miss the bending and displacement of the detached membrane, along with the localized stress concentrations that could determine whether the membrane reattaches, tears further, or remains stable during healing. The methodology builds on the team’s earlier FSI studies of flexible fins, baffles and partitions in convective systems, as well as their prior work applying FSI modeling to blood flow in abdominal aortic aneurysms under thermal treatment, adapting those engineering tools to the peculiar geometry and physiology of the human eye.

The choice to represent the detached Descemet membrane as a flexible structure rather than a fixed boundary is what gives the study its clinical bite. Prior models of aqueous humor flow, including foundational work on fluid flow in the anterior chamber of the human eye published decades ago, captured the buoyancy-driven currents but assumed static, impermeable walls. By letting the membrane move, the new simulations capture the interplay between hemodynamics-like fluid loading and tissue compliance—precisely the interplay that governs how a detached membrane flutters against the aqueous humor, how stresses concentrate at its edges and attachments, and how different graft stiffnesses redistribute those stresses across the corneal structure. The team’s results suggest that surgeons and biomaterials scientists selecting corneal grafts for patients prone to Descemet membrane detachment could use stress predictions of this kind to weigh graft stiffness as part of the decision, even though the overall thermal environment of the chamber will remain largely unchanged.

Beyond transplantation, the model has direct relevance to thermal therapy of the eye, a class of treatments in which controlled warming is applied to manage conditions of the anterior segment. Because the simulations connect an easily controlled clinical variable—the applied temperature difference—to a measurable outcome in convective heat transfer, and because they quantify the role of iris geometry in shaping the thermal flow field, they provide a template for patient-specific treatment planning. A clinician armed with imaging of a patient’s anterior chamber geometry could, in principle, use models of this type to predict how a planned thermal protocol will distribute heat in the presence of a detached membrane, and whether the resulting stresses on the membrane fall within tolerable limits.

The work is not without its simplifications, as the authors themselves frame the study as an evaluation of corneal transplantation processes rather than a complete clinical simulator. The anterior chamber geometry is idealized, the aqueous humor is treated with standard transport properties, and the elasticity modulus range, while broad, samples the problem in parametric steps rather than matching every individual patient’s tissue. Real eyes also feature aqueous production and drainage, blinking, saccadic motion and ocular pulse effects that a steady natural-convection FSI model does not capture. Nonetheless, the paper’s central contribution—demonstrating that corneal stiffness governs membrane stress while iris geometry and thermal gradient govern heat transfer—stands as a clean separation of effects that future, more detailed models will need to reproduce.

The research was supported by the Universiti Kebangsaan Malaysia Research Grant GP-2024-K006388 and by the Deanship of Research and Graduate Studies at King Khalid University through a large Research Group Project. As computational biomechanics continues to migrate from engineering journals into clinical planning, studies like this one mark a shift toward treating the eye not as a static optical instrument but as a living, deformable, fluid-filled machine—one in which a membrane thinner than a human hair can dominate the mechanical conversation, and where the difference between a compliant and a stiff cornea may one day inform the surgeon’s graft choice.

Monitoring blood oxygen saturation traditionally involves bulky, external devices or invasive methods that can cause discomfort and limit continuous observation. Pulse oximetry, the standard approach, relies on measurements from fingertips or earlobes, which can be affected by motion artifacts or poor perfusion. The emergence of smart contact lenses as a non-invasive interface offers a compelling alternative, given the eye’s rich vasculature and the unique optical properties of the cornea and conjunctiva. The research team’s novel approach leverages an intricately designed nanowire array, embedded within a flexible, biocompatible lens, to probe ocular blood oxygenation through advanced plasmonic interactions.

At the heart of this technology lies the principle of plasmonic nano-confinement, whereby localized surface plasmon resonances are tightly confined within metallic nanostructures, amplifying optical signals at specific wavelengths. The researchers engineered a precisely ordered array of nanowires with dimensions fine-tuned to achieve strong plasmonic coupling. This configuration magnifies subtle changes in the absorption spectra corresponding to varying oxygen saturation levels within the microvasculature of the eye. As a result, even minute fluctuations in blood oxygen levels manifest as clear, detectable optical signatures.

Fabricated using state-of-the-art nanolithography and nanoimprint techniques, the nanowire array is seamlessly integrated onto a flexible substrate that mimics the curvature and biomechanical properties of human corneal tissue. This ensures that the smart contact lens remains comfortable and stable during wear, avoiding irritation or disruption of normal vision. The flexible substrate also incorporates transparent conductive materials that facilitate signal transduction without compromising the user’s field of view or ocular health.

Data acquisition and processing occur through an embedded microelectronic system miniaturized to fit within the slim profile of the contact lens. This system includes a tiny light source that emits specific wavelengths optimized for plasmonic excitation, alongside photodetectors that capture reflected and transmitted signals altered by blood oxygen concentration. The onboard electronics filter and amplify these signals, converting them into digital data streams. This information is wirelessly transmitted to external devices such as smartphones or medical monitors, enabling continuous remote tracking of ocular oxygenation status.

Beyond mere technical prowess, this smart lens represents a leap forward in personalized medicine. Continuous, real-time monitoring opens new horizons in the management of chronic conditions like glaucoma, diabetic retinopathy, and systemic cardiovascular diseases, which can manifest ocular manifestations linked to hypoxia. Early detection of oxygen saturation anomalies could enable timely therapeutic interventions, potentially improving prognosis and reducing healthcare costs. Furthermore, in high-altitude or aviation contexts, the device could safeguard individuals exposed to hypoxic environments.

The integration of plasmonic nanostructures for biosensing within flexible electronics also addresses significant challenges related to miniaturization and sensitivity. Conventional optical sensors often struggle with low signal-to-noise ratios and limited spatial resolution when applied in wearable formats. The plasmonic nano-confinement approach effectively amplifies these signals at the nanoscale, while the nanowire array geometry ensures consistency and reproducibility across the sensor surface. This approach, therefore, elevates both performance and reliability in a compact design inherently suited for long-term usage.

Critically, biocompatibility and user safety were central considerations throughout the development process. The researchers employed materials known for ocular compatibility, minimizing risks of cytotoxicity or inflammatory responses. Rigorous in vitro and in vivo assessments confirmed the lens’s safe interaction with tear fluid and corneal epithelia over prolonged wear periods. Moreover, the device’s power consumption is optimized to ensure minimal heat generation, preserving ocular comfort and preventing adverse effects linked to thermal exposure.

Another remarkable aspect of this smart contact lens is its potential adaptability. The modular nature of the nanowire array allows tuning for detection of other biomarkers beyond blood oxygen saturation, such as glucose, lactate, or intraocular pressure. By coupling plasmonic biosensors with multiplexed electronic circuits, future iterations could evolve into multifunctional platforms providing a comprehensive ocular health profile accessible through a single, discreet interface.

From an engineering perspective, the fabrication methods were meticulously refined to ensure scalability and cost-effectiveness, crucial factors for mass-market adoption. Techniques such as roll-to-roll nanoimprinting and advanced lithographic processes were leveraged to produce uniform nanowire arrays over large lens areas. The choice of flexible substrates compatible with these processes ensures that industrial manufacturing can meet anticipated demand without compromising device quality or performance consistency.

The interdisciplinary nature of this work exemplifies the fusion of nanophotonics, materials science, biomedical engineering, and data analytics necessary to realize truly smart wearable devices. By seamlessly integrating these domains within a biocompatible, vision-compatible platform, the researchers have addressed fundamental barriers that have hindered the practical deployment of ocular biosensors. Their success marks a promising milestone toward widespread implementation of next-generation, non-invasive health monitoring technologies.

Looking ahead, clinical trials are envisioned to validate the device’s diagnostic utility across diverse patient populations with ocular and systemic diseases featuring hypoxic components. Regulatory pathways will need to be navigated, considering the device’s hybrid status as both a medical sensor and a contact lens. Nonetheless, the device’s non-invasive nature, coupled with its potential for continuous longitudinal data capture, strongly supports its integration into future healthcare ecosystems that emphasize preventive care and personalized medicine.

In conclusion, the advent of a smart contact lens embedding plasmonic nano-confinement nanowire arrays for ocular blood oxygen saturation monitoring represents a transformative advance poised to redefine how we perceive and manage health. Combining nanoscale optical engineering with flexible biocompatible electronics, this technology delivers unprecedented opportunities for real-time, non-invasive physiological sensing. As it moves from laboratory innovation toward clinical reality, it promises to enrich medical diagnostics and empower individuals with finer control over their well-being — all encapsulated within a seemingly simple, yet marvelously sophisticated, contact lens.

Subject of Research:
Non-invasive ocular biosensing; plasmonic nanostructures; blood oxygen saturation monitoring; smart contact lenses; flexible electronics; nanophotonics.

Article Title:
A smart contact lens with plasmonic nano-confinement nanowire array for non-invasive ocular blood oxygen saturation monitoring.

Article References:
Kan, X., Fan, Q., Guo, W. et al. A smart contact lens with plasmonic nano-confinement nanowire array for non-invasive ocular blood oxygen saturation monitoring. npj Flex Electron (2026). https://doi.org/10.1038/s41528-026-00614-9

Image Credits: AI Generated

Retinal imaging has long been constrained by the delicate interplay between resolution and depth of focus. The human retina, a multi-layered neural tissue about 300 micrometers thick, demands extraordinarily precise visualization to reveal structures at the single-cell level. Conventional high-resolution methods, especially those involving adaptive optics optical coherence tomography (AO-OCT), have offered unprecedented clarity but only within extremely thin focal planes. As a result, clinicians have historically faced the daunting task of sequentially refocusing and acquiring numerous scans across different retinal layers to capture a full picture—an approach that inevitably elongates examination times, complicates procedures, and increases susceptibility to motion artifacts induced by involuntary eye movements.

Led by the collaborative efforts of Dawid Borycki and Maciej Wojtkowski from the Institute of Physical Chemistry of the Polish Academy of Sciences’ International Centre for Translational Eye Research (ICTER), alongside Zhuolin Liu and Daniel X. Hammer from the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), the new study presents a paradigm shift. Rather than pursuing hardware complexity to gain extended depth of focus, the team has innovatively employed Computational Aberration Correction (CAC) to computationally extend the depth of field from a single, optimally positioned focus setting, enhancing retinal images across layers with no sacrifice in resolution.

At the heart of this work lies AO-OCT, a sophisticated hybrid imaging technology that fuses optical coherence tomography’s infrared imaging capabilities with adaptive optics’ real-time correction of ocular aberrations. AO-OCT can visualize intricate retinal structures such as photoreceptors, retinal ganglion cells, and capillaries at unparalleled resolutions. Despite its potential, the inherent limitation of a narrow depth of focus—often only tens of micrometers—has been a major obstacle to its broader clinical application. The retina’s rich layering necessitates viewing beyond these narrow planes, traditionally achievable only through laborious focus stacking.

The CAC algorithm ingeniously harnesses the rich phase and amplitude information contained in AO-OCT’s high-quality input data. Unlike superficial digital enhancements that merely smooth or sharpen images, CAC reconstructs sharpness for out-of-focus layers by computationally reassigning wavefront distortions, essentially “stitching” the depth of field in the computational domain. This method requires an optimal signal-to-noise ratio—the researchers identified a critical threshold of approximately 25 dB—to ensure the phase retrieval and correction are reliable and effective.

Through carefully designed experiments, the team determined the ideal focal plane for simultaneous multi-layer visualization lies at the inner plexiform layer (IPL), situated roughly midway through the retina. Focusing here capitalizes on relatively strong imaging signals from both deeper photoreceptor layers and more superficial ganglion cell layers. This strategic choice enables CAC to fully exploit the high signal quality, delivering a comprehensive, high-resolution image of the entire retinal thickness from a single acquisition, reducing scanning time significantly.

Testing their method on data from two human volunteers—a healthy 39-year-old and a 53-year-old patient with multiple sclerosis (MS) and a history of optic neuritis—offered meaningful insights into clinical applicability. MS-related neurodegeneration primarily affects retinal ganglion cells and the optic nerve head; however, effects on photoreceptors remain poorly understood due to difficulty in visualizing these layers simultaneously. The ability to image both inner and outer retinal layers concurrently using CAC-enhanced AO-OCT provides a new window into assessing disease impact with precision.

Another advantage stems from improved patient experience and diagnostic reliability. Reducing examination times by up to fivefold minimizes the effects of fatigue and involuntary eye movements, common sources of image degradation. Consequently, the new imaging protocol fosters not only faster clinical workflows but also enhanced image quality, enabling earlier detection of subtle pathological changes. This is particularly relevant for diseases such as age-related macular degeneration and diabetic retinopathy, where early intervention can dramatically alter patient outcomes.

Furthermore, the compatibility of the CAC algorithm with existing AO-OCT systems underscores the technique’s potential for seamless integration into clinical practice. While current computational reconstruction requires approximately 3.4 seconds per scan, the authors highlight that leveraging graphics processing unit (GPU) acceleration could reduce this to milliseconds, making near-real-time full-thickness retinal imaging a practical possibility.

The implications of this research extend beyond ophthalmology. Because the retina serves as a readily accessible part of the central nervous system, detailed cellular-resolution imaging can yield biomarkers relevant to a wide range of neurological disorders. Diseases like Alzheimer’s and Parkinson’s manifest early changes in retinal microstructures, opening avenues for non-invasive diagnosis and monitoring through retinal imaging—a prospect greatly enhanced by the newly extended depth-of-focus technique.

This innovative fusion of adaptive optics and computational aberration correction not only elevates the capabilities of retinal imaging but also exemplifies a formidable synergy between hardware and software in overcoming fundamental physical constraints. It illustrates a broader trend in biomedical optics: leveraging computational power to circumvent hardware limitations, ultimately delivering higher performance with streamlined instrumentation.

As the research community and clinical practitioners move forward, the focus will likely shift toward refining the CAC algorithm’s robustness, automating the selection of optimal focal planes, and integrating the technology into commercial imaging systems. This promises to democratize access to cellular-resolution retinal imaging, transforming the landscape of eye care diagnostics and research.

In summary, the advent of computational aberration correction enabling full-thickness AO-OCT represents a leap forward in how we visualize the retina. By attaining simultaneous clarity across retinal layers from a single focus, it paves the way for faster, more informed, and more patient-friendly ocular examinations. Such innovation holds the promise of earlier diagnoses, improved disease monitoring, and potentially, better prognostic outcomes for millions affected by eye and neurodegenerative diseases worldwide.

Subject of Research: Adaptive optics optical coherence tomography and computational aberration correction for enhanced retinal imaging

Article Title: Computational aberration correction enables full-thickness retinal imaging with adaptive optics optical coherence tomography

News Publication Date: February 2026

Web References: DOI: 10.1016/j.bbe.2026.02.002

References:
Borycki, D., Liu, Z., Hammer, D. X., & Wojtkowski, M. (2025). Computational aberration correction enables full-thickness retinal imaging with adaptive optics optical coherence tomography. Biocybernetics and Biomedical Engineering.

Image Credits: Photo by Karol Karnowski, ICTER

Understanding the PRPH2 gene’s crucial role in vision begins with recognizing the delicate architecture of photoreceptor cells in the retina. These cells are divided into rods and cones, each serving distinct functions in vision. Rods are responsible for vision in low-light conditions, while cones facilitate color vision and visual acuity in bright light. The PRPH2 gene is instrumental in the formation and maintenance of these cells. Any dysfunction or mutation in this genetic blueprint can disrupt the delicate balance required for optimal visual processing and may lead to degenerative conditions that degrade eyesight over time.

Retinal diseases associated with mutations in the PRPH2 gene are numerous and varied. The spectrum includes conditions such as retinitis pigmentosa, which leads to progressive loss of vision, and cone-rod dystrophies that affect both types of photoreceptor cells. The PRPH2 gene has over 300 known variants, each potentially corresponding to different retinal disorders. These diseases underscore the imperative for a thorough understanding of how such mutations interfere with the essential roles played by rods and cones, highlighting the urgency of the research initiated by the University of Houston team.

Professor Muna Naash, who leads the research team, emphasizes the study’s pivotal objective: to unveil the underlying mechanisms that connect faulty PRPH2 genes to the onset of retinal diseases. The complexity of these associations is profound; the research aims to elucidate how the disruption of PRPH2 affects the fundamental processes that govern photoreceptor structure and function. To achieve this, Naash and her colleague, Professor Muayyad Al-Ubaidi, are implementing innovative experimental models and therapeutic platforms that facilitate comprehensive examinations of the gene’s pathology.

A significant aspect of the research involves exploring the biochemical properties of PRPH2, alongside its critical binding partner known as retinal OS membrane protein 1. This exploration is essential because understanding these interactions is foundational for deciphering how PRPH2 contributes to the proper formation of photoreceptor outer segments. The formation of these segments is crucial for the function of rods and cones, and any impediments in this process can have far-reaching impacts on vision.

In addition to unraveling the architectural and functional roles of PRPH2, the researchers are working to address the scientific gap that currently exists in the development of effective therapies for PRPH2-related diseases. Despite advancements in genetic research, there are still no practical therapeutic options available for individuals suffering from conditions linked to this gene. Al-Ubaidi stresses the importance of developing targeted therapies, highlighting that understanding the specific mechanisms behind PRPH2 mutations is vital for designing successful treatment strategies.

The team is keenly aware that the journey toward effective gene therapies requires rigorous experimentation and validation. By developing models that mimic the pathological processes of PRPH2 disorders, they aim to identify potential treatment pathways and evaluate the efficacy of various therapeutic strategies. This methodical approach will not only advance the understanding of PRPH2’s role in retinal health but also catalyze the development of clinical interventions that could alleviate the burden of these devastating diseases.

Furthermore, exploring the intricate dynamics of protein transport within photoreceptor cells forms a critical component of their research. The transport mechanisms that transport proteins like peripherin 2 to their designated locations within rod and cone cells are fundamental for maintaining cellular integrity and function. Disruption in this transport may lead to mislocalization and eventual cell dysfunction, further complicating the pathology of retinal diseases.

Additionally, the research team’s focus extends beyond mere observation; they strive to create a comprehensive picture of how genetic mutations manifest clinically. By mapping the connections between genetic variants in the PRPH2 gene and associated retinal conditions, their work aims to illuminate previously obscure pathways that contribute to visual impairment.

As they embark on this challenging, yet promising, investigative path, Naash and Al-Ubaidi’s pursuit of knowledge serves as a beacon of hope for the hundreds of thousands affected by retinal diseases linked to PRPH2. By shedding light on the molecular intricacies of vision, they aspire to revolutionize current therapeutic approaches and ultimately offer new solutions for preserving sight.

The implications of their findings extend beyond the confines of academia; they represent a crucial step towards bridging the gap between genetic research and practical medical treatments. As the scientific community and public await the outcomes of this groundbreaking research, the potential to significantly impact the lives of individuals grappling with vision loss becomes increasingly tangible.

The research not only aligns with the urgent need for advancements in treating hereditary retinal diseases but also emphasizes the importance of funding and interdisciplinary collaboration in the biomedical field. By pooling expertise and resources, the researchers at the University of Houston are positioned to make substantial contributions that could change the landscape of therapeutic options for those affected by vision disorders.

In conclusion, the team led by Professors Naash and Al-Ubaidi at the University of Houston is embarking on a critical mission to unlock the mysteries of the PRPH2 gene and its role in retinal diseases. Through rigorous research and innovative experimental approaches, they aim to bridge the gap between foundational science and the development of viable therapeutic options. As they navigate the complexities of genetic interventions, the road lies ahead paved with both challenges and tremendous promise.

Subject of Research: Investigating the PRPH2 gene and its role in retinal diseases
Article Title: University of Houston Researchers Advance Knowledge on Vision Disorders through PRPH2 Gene Study
News Publication Date: October 2023
Web References: N/A
References: N/A
Image Credits: University of Houston

Keywords

Vision disorders, retinal diseases, genetic mutations, photoreceptor cells, gene therapy, blindness, biomedical research, University of Houston, eye health, PRPH2 gene